TNFSF10 and lung carcinoma: To support integration of 89Zr-oxine cell tracking into the TACTICAL trial, we have shown that TRAIL-expressing umbilical cord tissue-derived MSCs (MSCTRAIL) can be tracked non-invasively to the lungs in a preclinical lung cancer model up to 7 days post-injection.